Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia

NCT05884528 is registered in ClinicalTrials.gov with Merz Therapeutics GmbH as lead sponsor.

NCT NCT05884528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia
Lead sponsor
Merz Therapeutics GmbH
Phase
Observational
Overall status
Completed
Start date
July 8, 2023
Completion date
July 31, 2024
Enrollment
270 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia